Respire_final-01
  • CORPORATE
    • Company Overview
    • Board of Directors
    • RespireRx Organization Structure
    • Social Media Guidelines
  • NEUROTRANSMISSION
  • RESOLUTIONRX
    • Cannabinoid Platform Summary
    • Pharmaceutical Cannabinoids
    • Obstructive Sleep Apnea
    • Dronabinol for the Treatment of Obstructive Sleep Apnea
    • Regulatory Process
  • ENDEAVOURRX
    • Neuromodulators
    • Ampakines
      • AMPAkine Platform Summary
      • Lead Compounds
      • Attention Deficit Hyperactivity Disorder (ADHD)
      • Spinal Cord Injury (SCI)
    • GABAkines
      • GABAkines Platform Summary
      • Background
      • Epilepsy
      • Pain
  • PRODUCT PIPELINE
  • INVESTORS
    • Investor Contact
    • SEC Reports
    • News
    • FAQs
    • Presentations
  • CONTACT

Author: j3ff1

Home Articles Posted by j3ff1 (Page 4)
118 posts, 0 comments

11/22/2021 – RespireRx Pharmaceuticals Inc. Announces CEO’s OTC Venture Market Podcast

November 22, 2021j3ff1
Read More

WATCH: RespireRx CFO Jeff Margolis Discusses Clinical Pipeline with Proactive Investors

November 4, 2021j3ff1

RespireRx Pharmaceuticals (OTCQB:RSPI) CFO Jeff Margolis tells Proactive the Glen Rock, New Jersey-based group is advancing its slew of therapeutics throughout the clinical pipeline including a synthetic form of cannabinoid called dronabinol. Margolis says it aims to move to a Phase 3 clinical study to treat obstructive sleep apnea (OSA) with dronabinol. Meanwhile, Margolis says…

Read More

11/4/2021 – RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO

November 4, 2021j3ff1
Read More

6/8/2021 – RespireRx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference

June 8, 2021j3ff1
Read More

5/12/2021 – RespireRx Pharmaceuticals Inc. Announces New Data Regarding the Use of AMPAkines as Potential Treatments for Spinal Cord Injury

May 12, 2021j3ff1
Read More

4/22/2021 – RespireRx Pharmaceuticals Inc. Provides Update on Its Development Programs

April 22, 2021j3ff1
Read More

2/8/2021 – Corrected Headline: RespireRx Pharmaceuticals Up Listed to OTCQB and Ticker Returns to RSPI

February 8, 2021j3ff1
Read More

2/8/2021 – RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split

February 8, 2021j3ff1
Read More

1/8/2021 – RespireRx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences

January 8, 2021j3ff1
Read More

1/5/2021 – RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split

January 5, 2021j3ff1
Read More

Posts navigation

< 1 2 3 4 5 6 7 … 12 >

RespireRx Organization Structure

  • RespireRx Organization Structure
  • Arnold S. Lippa, PhD
    • Richard Purcell
    • David Dickason
    • James Cook
    • Jeffrey M. Witkin
    • Rok Cerne
  • Jeff Margolis
©2016 RespireRx Phamaceuticals Inc. All Rights Reserved.